SANA
Price
$1.82
Change
+$0.01 (+0.55%)
Updated
May 9 closing price
Capitalization
410.51M
82 days until earnings call
SAVA
Price
$1.77
Change
+$0.07 (+4.12%)
Updated
May 9 closing price
Capitalization
82.12M
81 days until earnings call
Ad is loading...

SANA vs SAVA

Header iconSANA vs SAVA Comparison
Open Charts SANA vs SAVABanner chart's image
Sana Biotechnology
Price$1.82
Change+$0.01 (+0.55%)
Volume$4.86M
Capitalization410.51M
Cassava Sciences
Price$1.77
Change+$0.07 (+4.12%)
Volume$1.15M
Capitalization82.12M
SANA vs SAVA Comparison Chart
Loading...
SANA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SAVA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
SANA vs. SAVA commentary
May 11, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is SANA is a Hold and SAVA is a Buy.

Ad is loading...
COMPARISON
Comparison
May 11, 2025
Stock price -- (SANA: $1.82 vs. SAVA: $1.77)
Brand notoriety: SANA and SAVA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: SANA: 149% vs. SAVA: 77%
Market capitalization -- SANA: $410.51M vs. SAVA: $82.12M
SANA [@Biotechnology] is valued at $410.51M. SAVA’s [@Biotechnology] market capitalization is $82.12M. The market cap for tickers in the [@Biotechnology] industry ranges from $296.96B to $0. The average market capitalization across the [@Biotechnology] industry is $2.18B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

SANA’s FA Score shows that 1 FA rating(s) are green whileSAVA’s FA Score has 1 green FA rating(s).

  • SANA’s FA Score: 1 green, 4 red.
  • SAVA’s FA Score: 1 green, 4 red.
According to our system of comparison, both SANA and SAVA are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

SANA’s TA Score shows that 5 TA indicator(s) are bullish while SAVA’s TA Score has 4 bullish TA indicator(s).

  • SANA’s TA Score: 5 bullish, 2 bearish.
  • SAVA’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, SANA is a better buy in the short-term than SAVA.

Price Growth

SANA (@Biotechnology) experienced а -3.70% price change this week, while SAVA (@Biotechnology) price change was +9.94% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -6.24%. For the same industry, the average monthly price growth was +9.39%, and the average quarterly price growth was -13.47%.

Reported Earning Dates

SANA is expected to report earnings on Jul 31, 2025.

SAVA is expected to report earnings on Jul 30, 2025.

Industries' Descriptions

@Biotechnology (-6.24% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SANA($411M) has a higher market cap than SAVA($82.1M). SANA YTD gains are higher at: 11.656 vs. SAVA (-25.000). SAVA has higher annual earnings (EBITDA): -141.15M vs. SANA (-289.51M). SANA has more cash in the bank: 199M vs. SAVA (129M). SAVA has less debt than SANA: SAVA (0) vs SANA (96.1M). SANA (0) and SAVA (0) have equivalent revenues.
SANASAVASANA / SAVA
Capitalization411M82.1M501%
EBITDA-289.51M-141.15M205%
Gain YTD11.656-25.000-47%
P/E RatioN/AN/A-
Revenue00-
Total Cash199M129M154%
Total Debt96.1M0-
FUNDAMENTALS RATINGS
SAVA: Fundamental Ratings
SAVA
OUTLOOK RATING
1..100
28
VALUATION
overvalued / fair valued / undervalued
1..100
23
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
90
PRICE GROWTH RATING
1..100
64
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
SANASAVA
RSI
ODDS (%)
Bullish Trend 2 days ago
87%
Bullish Trend 2 days ago
77%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
81%
MACD
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
88%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
83%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
77%
Bullish Trend 2 days ago
86%
Advances
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 2 days ago
83%
Declines
ODDS (%)
Bearish Trend 5 days ago
89%
Bearish Trend 5 days ago
87%
BollingerBands
ODDS (%)
N/A
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
78%
Bearish Trend 2 days ago
84%
View a ticker or compare two or three
Ad is loading...
SANA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SAVA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CTM0.980.05
+5.82%
Castellum
ENGQF20.920.92
+4.60%
ENGIE SA
SOMMY12.280.26
+2.14%
Sumitomo Chemical Co., Ltd.
LQMT0.11N/A
+1.10%
Liquidmetal Technologies, Inc.
ACSAY12.650.06
+0.48%
ACS Actividades De Construccion Y Servicios SA

SAVA and

Correlation & Price change

A.I.dvisor indicates that over the last year, SAVA has been loosely correlated with CRSP. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if SAVA jumps, then CRSP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SAVA
1D Price
Change %
SAVA100%
+4.12%
CRSP - SAVA
35%
Loosely correlated
-1.44%
IBRX - SAVA
29%
Poorly correlated
-0.96%
LXRX - SAVA
26%
Poorly correlated
+1.73%
AMRN - SAVA
26%
Poorly correlated
-2.80%
VKTX - SAVA
26%
Poorly correlated
-1.08%
More